HRV Pharma, Haleos Labs partner to develop, manufacture orphan and niche APIs
HRV Pharma and Haleos Labs have joined forces in a multi-year strategic partnership to fast-track the development and manufacturing of specialized active pharmaceutical ingredients (APIs) for rare diseases and niche therapies. This collaboration leverages HRV’s global market access and Haleos’ manufacturing expertise to introduce 5-7 new high-value molecules annually, targeting underserved patient populations worldwide.🕒 1 min read
HRV Pharma and Haleos Labs have joined forces in a multi-year strategic partnership to fast-track the development and manufacturing of specialized active pharmaceutical ingredients (APIs) for rare diseases and niche therapies. This collaboration leverages HRV’s global market access and Haleos’ manufacturing expertise to introduce 5-7 new high-value molecules annually, targeting underserved patient populations worldwide.
Continue Reading
-
Here’s Why Richa Chadha Turned Vegan, Check Out Here Favourite Foods
- BCCI To Conduct Additional Bone Test For Age Determination In Junior Cricket
-
Government’s Big Move To Check Inflated Hospital Bills Due To Insurers: Report
- Nandan Nilekani at 71: Steering Infosys through two critical successions
-
Delhi High Court Allows Sunjay Kapur’s Wife Priya To File Property Papers In Sealed Cover
- Rare Copy Of Comic Book That Introduced World To Superman Sells For $15 Million
- Chris Woakes May Opt For Rehab Over Shoulder Surgery To Be Fit For Ashes
- Russian Missile Designer Alexander Leonov Who Developed Brahmos Dies At 74
-
Ravichandran Ashwin ‘Disappointed’ Over Two Veteran Stars Missing T20 World Cup
-
“B Team Of Disruptive Elements”: Education Minister Dharmendra Pradhan To NDTV On CJP